RxDoctor Payments Data

Brad Hammon, DO

Dermatology · Reno, NVNPI 1114388204

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.9% of the total across 316 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,894, 3.1 times the $608 reported in 2019.

$7,158in general payments, 2019–2025

Across 316 payments — averaging $22.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Lilly USA, LLC$854
  • Novartis$694
  • Sanofi$493
  • Johnson & Johnson$484
  • Sun Pharmaceutical Industries Inc.$432
  • plus $3K from 21 others

What the payments were for

  • Food & beverage$6,86696%
  • Education$2924%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,158 in reported general payments places this provider in the 60th percentile of 78 dermatology providers in Nevada.

See all dermatology providers in Nevada

Medicare billing

Part B allowed, 2024
$221,198
Medicare patients
635
Services billed
4,335

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab15$184,944
Dupixent PenDupilumab29$109,652
Clobetasol Propionate52$3,149
Ketoconazole155$2,031
Triamcinolone Acetonide153$1,413
Mupirocin98$1,084
Mometasone Furoate33$685
Doxycycline Monohydrate58$648
Betamethasone Dipropionate15$571
CiclopiroxCiclopirox Olamine23$459
Ciclopirox11$396
Clindamycin Phosphate14$385
ValacyclovirValacyclovir Hcl35$383
Terbinafine Hcl27$264
Fluocinonide13$241

Paid to pharmacies, not to this prescriber.

Other dermatology in Reno

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →